Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
trial enrollment
CRO
AI model sped up trial screening time by 40%, NIH study finds
TrialGPT correctly matched patients to trials 87.3% of the time, close to the numbers seen in human experts, 88.7% to 90%.
Darren Incorvaia
Nov 25, 2024 1:45am
Takeda stops phase 2 post-anesthesia trial over slow enrollment
Oct 31, 2024 5:29am
Kezar suspends key lupus study after 4 deaths
Sep 30, 2024 11:23am
Genfit moves to jump-start enrollment in liver failure trial
Sep 20, 2024 9:47am
Amgen, Merck join academic clinical trial diversity partnership
Sep 16, 2024 3:10pm
Genentech program doubles pace of diverse patient enrollment
Aug 5, 2024 3:15pm